SEC Form 4 · accession 0001179110-18-012629
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Alan Goldberg
Director
Period of report
Nov 6, 2018
Accepted (ET)
Nov 7, 2018 · 9:54 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 6, 2018 | P | 30,000 | $5.76 | A | 53,800 | D |
Table II — derivative securities
No Table II lines on this filing.